BENGALURU: To provide parents and students with an opportunity to understand the facilities and infrastructure available on ...
In late May 2026, Ellipses Pharma and partner Sichuan Kelun-Biotech Biopharmaceutical reported pivotal trial data at ASCO showing strong efficacy and manageable safety for lunbotinib (EP0031/A400) and ...
Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, ...
The European Commission has published an analysis detailing the benefits of enacting the European Biotech Act, which was ...
Oncotelic Therapeutics is advancing delivery-focused technologies intended to potentially improve exposure consistency and therapeutic performance. Nanotechnology-enabled drug delivery has emerged as ...
The Piedmont Triad region’s hottest tech ticket on May 27 was 2026 Triad BioNight, where more than 400 business, academic and ...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the results of the Phase III clinical study OptiTROP-Lung05 ...
Infineon Technologies, which makes microchips, will invest more than $2 million in Kentucky and create 20 new jobs in the ...
A cooperation program under the KOICA IBS project was launched in Luu Kiem ward, Hai Phong city, on May 26 with a view to ...
CHENGDU, China, May 29, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that at the 2026 American Society of Clinical Oncology (ASCO) ...
The Department of Interior and Local Government (DILG) on Tuesday reiterated its call to local government units to streamline ...
Access to AI Developer Cloud Resources is Expected to be Utilized to Support Modeling of Energy-Efficient Semiconductor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results